Bacteria Isolated from Antarctic Permafrost are Efficient Antibiotic Producers
- 作者: Efimenko T.A.1, Efremenkova O.V.1, Demkina E.V.2, Petrova M.A.3, Sumarukova I.G.1, Vasilyeva B.F.1, El’-Registan G.I.2
-
隶属关系:
- Gause Institute of New Antibiotics
- Research Center of Biotechnology, Russian Academy of Sciences
- Institute of Molecular Genetics, Russian Academy of Sciences
- 期: 卷 87, 编号 5 (2018)
- 页面: 692-698
- 栏目: Experimental Articles
- URL: https://bakhtiniada.ru/0026-2617/article/view/163683
- DOI: https://doi.org/10.1134/S0026261718050089
- ID: 163683
如何引用文章
详细
Nontraditional sources were shown to be promising for obtaining bacterial isolates characterized by efficient production of antibiotics, including those affecting the strains with multidrug resistance. From Antarctic permafrost, 32 bacterial strains were isolated, and their ability to synthesize antimicrobal compounds efficient against 12 test strains, including the ones with multidrug resistance, was studied in submerged cultures. Out of 13 strains producing antibiotic compounds with different spectra of action, seven were chosen for further study. Their species identification was carried out by microbiological techniques and by analysis of their 16S rRNA gene sequences. Six strains of spore-forming bacteria were identified as Bacillus species (B. licheniformis, B. mojavensis, B. safensis, and B. subtilis), while one strain was identified as Gordonia terrae. Antimicrobial activity of two B. mojavensis strains (INA 01149 and INA 01151), two B. safensis strains (INA 01153 and INA 01154), and B. licheniformis strain INA 01155 against the antibiotic-resistant tester strain Leuconostoc mesenteroides VKPM B-4177 (VR) was revealed. Antibiotic activity of two B. safensis strains (INA 01153 and INA 01154) against tester bacteria, including Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus INA 00761 with multidrug resistance has not been reported previously. Antibiotic producers isolated from Antarctic permafrost samples are of interest to medicine due to the global issue of increasing antibiotic resistance of pathogenic bacteria.
作者简介
T. Efimenko
Gause Institute of New Antibiotics
编辑信件的主要联系方式.
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
O. Efremenkova
Gause Institute of New Antibiotics
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
E. Demkina
Research Center of Biotechnology, Russian Academy of Sciences
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
M. Petrova
Institute of Molecular Genetics, Russian Academy of Sciences
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
I. Sumarukova
Gause Institute of New Antibiotics
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
B. Vasilyeva
Gause Institute of New Antibiotics
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
G. El’-Registan
Research Center of Biotechnology, Russian Academy of Sciences
Email: efimen@inbox.ru
俄罗斯联邦, Moscow
补充文件
